Search research articles
Contact Us
Filters
Showing results (261-270 of 293) with videos related to
Page
of 30
Sort By:
Journal of Virology
|
August 13, 2024
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designs
Zekun Mu, Jill Whitley, Diana Martik, et al.
Science Immunology
|
July 20, 2022
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Jinyi Tang, Cong Zeng, Thomas M Cox, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 20, 2026
Targeting DNA-LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and Specificity
Nicolas Marzolini, Taylor V Brysgel, Ryan J Rahman, et al.
Cell Reports
|
March 16, 2022
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice
Zekun Mu, Kevin Wiehe, Kevin O Saunders, et al.
NPJ Vaccines
|
April 10, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O Saunders, Norbert Pardi, Robert Parks, et al.
Elife
|
August 19, 2015
A molecular tweezer antagonizes seminal amyloids and HIV infection
Edina Lump, Laura M Castellano, Christoph Meier, et al.
NPJ Vaccines
|
November 7, 2021
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O Saunders, Norbert Pardi, Robert Parks, et al.
Science Advances
|
March 27, 2026
One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine development
Nathan A Ona, Dapeng Zhang, Lisa C Lindesmith, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
December 6, 2021
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials
Jill Whitley, Christopher Zwolinski, Christian Denis, et al.
Nature Biotechnology
|
May 20, 2021
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
Tanja Rothgangl, Melissa K Dennis, Paulo J C Lin, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 293) with videos related to
Sort By:
Page
of 30
Journal of Virology
|
August 13, 2024
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designs
Zekun Mu, Jill Whitley, Diana Martik, et al.
Science Immunology
|
July 20, 2022
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Jinyi Tang, Cong Zeng, Thomas M Cox, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 20, 2026
Targeting DNA-LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and Specificity
Nicolas Marzolini, Taylor V Brysgel, Ryan J Rahman, et al.
Cell Reports
|
March 16, 2022
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice
Zekun Mu, Kevin Wiehe, Kevin O Saunders, et al.
NPJ Vaccines
|
April 10, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O Saunders, Norbert Pardi, Robert Parks, et al.
Elife
|
August 19, 2015
A molecular tweezer antagonizes seminal amyloids and HIV infection
Edina Lump, Laura M Castellano, Christoph Meier, et al.
NPJ Vaccines
|
November 7, 2021
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
Kevin O Saunders, Norbert Pardi, Robert Parks, et al.
Science Advances
|
March 27, 2026
One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine development
Nathan A Ona, Dapeng Zhang, Lisa C Lindesmith, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
December 6, 2021
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials
Jill Whitley, Christopher Zwolinski, Christian Denis, et al.
Nature Biotechnology
|
May 20, 2021
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
Tanja Rothgangl, Melissa K Dennis, Paulo J C Lin, et al.
Page
of 30